168 related articles for article (PubMed ID: 16313865)
21. Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt.
Zhao D; Zhang G; Wang M; Zhang C; Li J
Clin Mol Hepatol; 2019 Jun; 25(2):210-217. PubMed ID: 30897897
[TBL] [Abstract][Full Text] [Related]
22. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding.
Garbuzenko DV
Curr Med Res Opin; 2016; 32(3):467-75. PubMed ID: 26804426
[TBL] [Abstract][Full Text] [Related]
23. Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?
Cholongitas E; Papatheodoridis GV; Vangeli M; Terreni N; Patch D; Burroughs AK
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1079-89. PubMed ID: 16305721
[TBL] [Abstract][Full Text] [Related]
24. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
Farnsworth N; Fagan SP; Berger DH; Awad SS
Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
[TBL] [Abstract][Full Text] [Related]
25. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
26. Portosystemic shunts in children: a 15-year experience.
Botha JF; Campos BD; Grant WJ; Horslen SP; Sudan DL; Shaw BW; Langnas AN
J Am Coll Surg; 2004 Aug; 199(2):179-85. PubMed ID: 15275870
[TBL] [Abstract][Full Text] [Related]
27. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.
Lebrec D; Giuily N; Hadengue A; Vilgrain V; Moreau R; Poynard T; Gadano A; Lassen C; Benhamou JP; Erlinger S
J Hepatol; 1996 Aug; 25(2):135-44. PubMed ID: 8878773
[TBL] [Abstract][Full Text] [Related]
28. Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study.
Fares N; Robic MA; Péron JM; Muscari F; Otal P; Suc B; Vinel JP; Bureau C
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):21-26. PubMed ID: 29049129
[TBL] [Abstract][Full Text] [Related]
29. Current status and future possibilities of transjugular intrahepatic portosystemic shunts in the management of portal hypertension.
Radosevich PM; LaBerge JM; Gordon RL
World J Surg; 1994; 18(5):785-9. PubMed ID: 7975701
[TBL] [Abstract][Full Text] [Related]
30. Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.
Selim N; Fendley MJ; Boyer TD; Galloway JR; Branum GD
Ann Surg; 1998 Apr; 227(4):600-3. PubMed ID: 9563552
[TBL] [Abstract][Full Text] [Related]
31. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
[TBL] [Abstract][Full Text] [Related]
32. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
Brown RS; Lake JR
Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
[TBL] [Abstract][Full Text] [Related]
33. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
34. Transjugular intrahepatic portosystemic shunt as a bridge to non-hepatic surgery in cirrhotic patients with severe portal hypertension: a systematic review.
Lahat E; Lim C; Bhangui P; Fuentes L; Osseis M; Moussallem T; Salloum C; Azoulay D
HPB (Oxford); 2018 Feb; 20(2):101-109. PubMed ID: 29110990
[TBL] [Abstract][Full Text] [Related]
35. Perioperative Care of Patients With Liver Cirrhosis: A Review.
Abbas N; Makker J; Abbas H; Balar B
Health Serv Insights; 2017; 10():1178632917691270. PubMed ID: 28469455
[TBL] [Abstract][Full Text] [Related]
36. The management of the cirrhotic patient after transjugular intrahepatic portosystemic shunt.
Sanyal AJ
Semin Gastrointest Dis; 1997 Oct; 8(4):188-99. PubMed ID: 9360283
[TBL] [Abstract][Full Text] [Related]
37. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G
Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
[TBL] [Abstract][Full Text] [Related]
38. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
39. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F
Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935
[TBL] [Abstract][Full Text] [Related]
40. Distal splenorenal shunt: preferred treatment for recurrent variceal hemorrhage in the patient with well-compensated cirrhosis.
Elwood DR; Pomposelli JJ; Pomfret EA; Lewis WD; Jenkins RL
Arch Surg; 2006 Apr; 141(4):385-8; discussion 388. PubMed ID: 16618897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
